Glenzer Pharmaceuticals Private Limited
About Glenzer Pharmaceuticals Private Limited
Data last updated:
Glenzer Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 19 March 2013.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2013PTC249544.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Dev Raj Goyal and Sarabjit Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at C – 167 Plot No 25 Saraswati Kunj Society I P Extn.Patparg, Anj, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹10,000, a decline of 80% compared to the previous year. For the same year it recorded a net profit of ₹22,559 (net margin 225.6%) and EBITDA of ₹5,000 (EBITDA margin 50%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years.
Company details
Contact details
Glenzer Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 167 Plot No 25 Saraswati Kunj Society I P Extn.Patparg, Anj, Delhi, India – 110092
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Glenzer Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glenzer Pharmaceuticals Private Limited
FY 2024 filings availableGlenzer Pharmaceuticals Private Limited reported revenue of ₹10,000 (down 80% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over three years, including a 80% fall in the latest year. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,559 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 50% | ||||
| Net Profit Margin | 225.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glenzer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glenzer Pharmaceuticals Private Limited
Glenzer Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dev Raj Goyal | Director | 19 Mar 2013 | 13 Years 7 Months | As last reported |
| Sarabjit Singh | Director | 14 Nov 2013 | 12 Years 11 Months | As last reported |
| Arun Kumar | Director | 11 Jan 2016 | 10 Years 9 Months | As last reported |
Peer comparison
Glenzer Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ramgyan Pharmaceuticals Private Limited | ₹11,500 (FY 2024) | Delhi, India | ||||
| Life Stance Pharmaceuticals Private Limited | ₹11,245 (FY 2025) | Pune, Maharashtra, India | ||||
| Suchi Pharmaceuticals Private Limited | ₹10,800 (FY 2022) | Noida, Uttar Pradesh, India | ||||
| Shri Hari Drugs and Pharmaceuticals Private Limited | ₹10,500 (FY 2022) | -21.0% | Mumbai, Maharashtra, India | |||
| Tia Pharmaceuticals Private Limited | ₹10,040 (FY 2025) | -65.0% | Naraingarh, Haryana, India | |||
| Glenzer Pharmaceuticals Private Limitedthis company | ₹10,000 (FY 2024) | ₹22,559 | 225.6% | -80.0% | Delhi, India | |
| VNW Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -78.0% | Thane, Maharashtra, India | |||
| Encyclia Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -100.0% | Delhi, India | |||
| Ordell Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | Kolkata, West Bengal, India | ||||
| Wise Health Pharmaceuticals Private Limited | ₹10,000 (FY 2021) | Jabalpur, Madhya Pradesh, India | ||||
| Cadlac Pharmaceuticals Private Limited | ₹10,000 (FY 2025) | -96.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Glenzer Pharmaceuticals Private Limited, buy the company report.
Auditor
Glenzer Pharmaceuticals Private Limited is audited by GUPTA PUNEET & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA PUNEET & ASSOCIATES | FY 2017 | 028831N |
Shareholding
The shareholding of Glenzer Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Glenzer Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glenzer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glenzer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glenzer Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glenzer Pharmaceuticals Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Arun Kumar ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
Glenzer Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Glenzer Pharmaceuticals was a private limited company based in Delhi, India. The company worked in other wholesale, within the trading industry. It was incorporated on 19 March 2013 and is registered under CIN U24297DL2013PTC249544. The company has been struck off by the Registrar of Companies and is no longer operational.
Glenzer Pharmaceuticals had 3 directors:
- Dev Raj Goyal - Director
- Sarabjit Singh - Director
- Arun Kumar - Director
The CIN (Corporate Identification Number) of Glenzer Pharmaceuticals is U24297DL2013PTC249544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Glenzer Pharmaceuticals is at C – 167 Plot No 25 Saraswati Kunj Society I P Extn.Patparg, Anj, Delhi, India – 110092.
Glenzer Pharmaceuticals was incorporated on 19 March 2013. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Glenzer Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
Glenzer Pharmaceuticals operated in the trading industry, in the other wholesale segment. It worked in this industry before it was struck off.
The peers of Glenzer Pharmaceuticals by revenue are Ramgyan Pharmaceuticals Private Limited, Life Stance Pharmaceuticals Private Limited, Suchi Pharmaceuticals Private Limited, Shri Hari Drugs and Pharmaceuticals Private Limited, Tia Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arun Kumar ceased to be Additional Director on 30 Sep 2016. Kiran ceased to be Director on 12 Jan 2016. Arun Kumar was appointed as Director on 11 Jan 2016. Glenzer Pharmaceuticals has 6 board changes on record in total.
The compliance status of Glenzer Pharmaceuticals is compliant as of 22 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
